UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 8, 2007
IMMTECH PHARMACEUTICALS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
1-14907 |
39-1523370 (IRS Employer Identification No.) | |
One North End Avenue New York, New York |
10282 | ||
|
(212) 791-2911 (Registrants telephone number, including area code) |
| |
|
|
| |
|
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 8.01. |
Other Events. |
On February 8, 2007, the Company issued a press release entitled, Immtech Announces Registered Offering of $6.75 Million in Common Stock. The press release is filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Item 9.01 |
Financial Statements and Exhibits. |
|
(d) Exhibits |
Exhibit Number |
Description |
99.1 |
Press Release entitled, Immtech Announces Registered Offering of $6.75 Million in Common Stock, dated February 8, 2007 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
IMMTECH PHARMACEUTICALS, INC. |
|
By: |
/s/ Eric L. Sorkin |
|
|
Eric L. Sorkin |
|
|
Chief Executive Officer and President |
Date: |
February 8, 2007 |
EXHIBIT INDEX
Exhibit Number |
Description |
99.1 |
Press Release entitled, Immtech Announces Registered Offering of $6.75 Million in Common Stock, dated February 8, 2007 |